SEC Tracker
Get the app

Possible new Medicus Pharma shares

MDCXDilution

Known so far: no new shares from the prospectus covers read · shelf room about $9.4M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $9.4M
  • One third of float $9.4M ($28.3M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $9.4M on the S-3 of Jan 30, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $28.3M public float stated as of Jun 30, 2025, $9.4M, nothing sold off it in the last 12 months. Sources: S-3 Jan 30, 2026, effective Feb 4, 2026 · public float, as of Jun 30, 2025.

What could become new Medicus Pharma (MDCX) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (63.2M shares, +255% from 17.8M on Aug 11, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

63.2M

Mar 2025 to Aug 2026: from 13.4M to 63.2M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.